Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Communication Strategies. Case Studies. Applied Knowledge.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
This is an On-demand recording from March 2022.
This event is brought to you by
While UDI and other product labeling information have typically been maintained separately from other regulatory information, the growing complexity of supporting multiple markets is introducing compliance challenges. Companies can’t treat it simply as an operational or supply chain process.
Regulatory professionals are spending an increased amount of time focusing on UDI due to the implementation of the FDA UDI, the introduction of new UDI requirements in the EU MDR and EU IVDR regulations, and many countries around the world implementing aspects of UDI.
This virtual program will break down the complexity of UDI by exploring requirements across several major markets, including the types of devices that are covered and the expected implementation timelines.
Attendees will learn:
TBD
The agenda may vary based on changing requirements.
Instructors:
Bruce McKean is the director of regulatory at Rimsys Regulatory Management Software. He has more than 25 years of medical device industry experience as a regulatory professional specializing in quality and regulatory (Q&R) compliance, design controls, and Q&R-related mergers and acquisitions. During his career, McKean has focused on implementing and maintaining design controls, product submissions, quality management systems internal to his company and for newly acquired companies, corporate Q&R internal audit programs, and performing Q&R due diligence audits on target companies. Prior to joining Rimsys, he served as director of Q&R operations at Philips Healthcare, where he led a corporate-wide Medical Device Single Audit Program (MDSAP) compliance initiative and was focused on the implementation of the EU Medical Device Regulation (EU MDR).
James Gianoutsos is the founder and president of Rimsys Regulatory Management Software, a cloud-based solution to digitize, automate and create regulatory order for medtech companies. Gianoutsos is a quality assurance and regulatory affairs professional, who has a diverse background in the medical device, pharmaceutical and biologics industries. His professional experience includes the design, premarket approval, clinical trials, manufacturing, distribution and postmarket surveillance of drug products and Class I, II, and III devices. Gianoutsos has extensive experience in establishing and maintaining quality management systems in accordance with FDA, ISO, cGMP, MDD, MDR, MDSAP and CMDCAS requirements and standards, and has helped develop and submit multiple regulatory filings including Premarket Approvals (PMA), 510(k)s, design dossiers, technical files and Investigational New Drug Applications (INDs). He holds an MBA with a concentration in operations management and strategy from the University of Pittsburgh – Katz Graduate School of Business.